Related Experiment Video
Updated: Jul 15, 2025

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity
Yuwei Zhang1,2, Lina Sui1,2, Qian Du1
1Naomi Berrie Diabetes Center & Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York, 10032, United States.
Specific insulin gene (INS) mutations cause permanent neonatal diabetes mellitus (PNDM) by impairing beta cell function. This study reveals these mutations disrupt endoplasmic reticulum homeostasis, leading to beta cell loss and dedifferentiation.
Area of Science:
- Endocrinology
- Genetics
- Cell Biology
Background:
- Permanent neonatal diabetes mellitus (PNDM) is a severe form of diabetes caused by beta cell failure.
- Heterozygous mutations in the insulin (INS) gene are a known genetic cause of PNDM.
Approach:
- Investigated beta cell failure mechanisms in two PNDM patients with distinct INS mutations.
- Utilized human embryonic stem cells (hESCs) with INS mutations to study proinsulin processing and endoplasmic reticulum (ER) homeostasis in vitro.
- Transplanted patient-derived stem cell-derived beta (SC-beta) cells into NSG mice to assess in vivo function and identify dominant-negative effects.
Key Points:
- INS mutations lead to the accumulation of misfolded proinsulin and impaired proinsulin processing.
- These mutations disrupt ER homeostasis, causing beta cell loss and functional decline.
- Observed beta cell dedifferentiation, marked by altered marker expression, in addition to apoptosis.
Conclusions:
- INS mutations contribute to PNDM through both established (apoptosis) and novel (dedifferentiation) mechanisms.
- Understanding these pathways is crucial for developing targeted therapies for PNDM.
- Highlights the critical role of ER homeostasis in maintaining beta cell function and mass.
More Related Videos
09:35A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...